CT findings of completely regressed hepatocellular carcinoma with main portal vein tumor thrombosis after transcatheter arterial chemoembolization

Korean Journal of Radiology

Volumn 11, Issue 1, 2010, Pages 69-74

  Yoon, Jeong Hee ^a   Kim, Hyo Cheol ^a   Chung, Jin Wook ^a   Yoon, Jung Hwan ^b   Jae, Hwan Jun ^a   Park, Jae Hyung ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Chemoembolization; Hepatocellular carcinoma; Portal vein thrombosis

Indexed keywords

ALPHA FETOPROTEIN; CISPLAN; CISPLATIN; DOXORUBICIN; IODINATED POPPYSEED OIL; MITOMYCIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; DRUG INFUSION; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; MALE; MEDICAL RECORD REVIEW; PORTAL VEIN; PORTAL VEIN THROMBOSIS; PROTEIN BLOOD LEVEL; RADIOLOGIST; RESIDUAL THROMBOSIS; RETROSPECTIVE STUDY; THROMBOSIS; TUMOR RECURRENCE; TUMOR THROMBUS; VEIN DIAMETER;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; PORTAL VEIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 76049130141     PISSN: 12296929     EISSN: None     Source Type: Journal    
DOI: 10.3348/kjr.2010.11.1.69     Document Type: Article

References (15)

1. El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008;134:1752-1763
2. Shin SW. The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma. Korean J Radiol 2009;10:425-434
3. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003;37:429-442
4. Myung SJ, Yoon JH, Gwak GY, Shin CM, Ahn DW, Yu SJ, et al. A case of infiltrative hepatocellular carcinoma with main portal vein tumor thrombosis successfully treated by transarterial chemoembolization. Korean J Hepatol 2006;12:107-111 [Korean]
5. Georgiades CS, Hong K, D'Angelo M, Geschwind JF. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 2005;16:1653-1659
6. Chung JW, Park JH, Han JK, Choi BI, Han MC. Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization. AJR Am J Roentgenol 1995;165:315-321
7. Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer 1997;79:2087-2094
8. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983;148:397-401
9. Obi S, Yoshida H, Toune R, Unuma T, Kanda M, Sato S, et al. Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion. Cancer 2006;106:1990-1997
10. Kim DY, Park W, Lim DH, Lee JH, Yoo BC, Paik SW, et al. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma. Cancer 2005;103:2419-2426
11. Jeon UB, Chung JW, Cho YK, Park JH, Jae HJ, So YH. Superselective cisplatin infusion after conventional transarterial chemoembolization for the patients with hepatocellular carcinoma invading main portal vein. The Radiological Society of North America 93th Scientific Assembly and Annual Meeting, 2007
12. Mathieu D, Grenier P, LardéD, Vasile N. Portal vein involvement in hepatocellular carcinoma: dynamic CT features. Radiology 1984;152:127-132
13. Shah ZK, McKernan MG, Hahn PF, Sahani DV. Enhancing and expansile portal vein thrombosis: value in the diagnosis of hepatocellular carcinoma in patients with multiple hepatic lesions. AJR Am J Roentgenol 2007;188:1320-1323
14. Tublin ME, Dodd GD 3rd, Baron RL. Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR Am J Roentgenol 1997;168:719-723
15. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-430